In vitro and in vivo Human Metabolism of (S)-[18F]Fluspidine – A Radioligand for Imaging σ1 Receptors With Positron Emission Tomography (PET)
(S)-[18F]fluspidine ((S)-[18F]1) has recently been explored for positron emission tomography (PET) imaging of sigma-1 receptors in humans. In the current report, we have used plasma samples of healthy volunteers to investigate the radiometabolites of (S)-[18F]1 and elucidate their structures with LC...
Main Authors: | Friedrich-Alexander Ludwig, Steffen Fischer, Richard Houska, Alexander Hoepping, Winnie Deuther-Conrad, Dirk Schepmann, Marianne Patt, Philipp M. Meyer, Swen Hesse, Georg-Alexander Becker, Franziska Ruth Zientek, Jörg Steinbach, Bernhard Wünsch, Osama Sabri, Peter Brust |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00534/full |
Similar Items
-
Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (<i>S</i>)-(−)-[<sup>18</sup>F]Fluspidine in Glioblastoma
by: Magali Toussaint, et al.
Published: (2020-05-01) -
Dealing with PET radiometabolites
by: Ghosh, Krishna Kanta, et al.
Published: (2020) -
[<sup>18</sup>F]Fluspidine—A PET Tracer for Imaging of σ<sub>1</sub> Receptors in the Central Nervous System
by: Friedrich-Alexander Ludwig, et al.
Published: (2024-01-01) -
Characterization of a Novel M4 PAM PET Radioligand [11C]PF06885190 in Nonhuman Primates (NHP)
by: Sangram Nag, et al.
Published: (2023-06-01) -
Association between Individual Norepinephrine Transporter (NET) Availability and Response to Pharmacological Therapy in Adults with Attention-Deficit/Hyperactivity Disorder (ADHD)
by: Jue Huang, et al.
Published: (2022-07-01)